TITLE

Nitric oxide metabolites as biomarkers for follow-up after chronic rhinosinusitis surgery

AUTHOR(S)
Deroee, Armin Farajzadeh; Naraghi, Mohsen; Sontou, Alain Fabrice; Ebrahimkhani, Mohammad Reza; Dehpour, Ahmad Reza
PUB. DATE
March 2009
SOURCE
American Journal of Rhinology & Allergy;Mar2009, Vol. 23 Issue 2, p159
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Nitric oxide (NO) has a variety of effects on the pathophysiology of the nasal cavity and seems to play an important role in inflammation. It is increased in the common cold but decreased in acute and chronic rhinosinusitis (CRS). Exhaled NO increases after endoscopic sinus surgery in CRS. In our previous study we showed that NO metabolite (nitrate and nitrite) levels are increased in the sinus cavity of CRS patients. We hypothesized that NO metabolite levels are increased to normal in the nasal lavage of CRS patients after endoscopic sinus surgery and NO metabolites in the nasal lavage can be used as indicators of the disease status after surgery. Methods: This study was performed on 52 patients with CRS who did not respond to medical therapy and who underwent surgery. NO metabolite levels were measured in nasal lavages of the patients before surgery and 2 months after surgery. Results: NO metabolite levels (mean ± SEM) were 18.11 ± 3.08 μmol/L and 35.97 ± 4.64 μmol/L in nasal lavages of patients before and after surgery, respectively. The levels of NO metabolites were increased significantly (p < 0.01) after surgery in nasal lavages and patients reported significant improvement based on the visual analog scoring after the operation. Conclusion: NO metabolite levels were decreased in nasal lavages of CRS patients and were increased to normal levels after surgery along with improvement of the disease. NO metabolite levels may be used as an indicator for the follow-up of patients after endoscopic sinus surgery.
ACCESSION #
48689068

 

Related Articles

  • Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis. Rejdak, K.; Petzold, A.; Kocki, T.; Kurzepa, J.; Grieb, P.; Turski, W. A.; Stelmasiak, Z. // Journal of Neural Transmission;Aug2007, Vol. 114 Issue 8, p1011 

    The study aimed to assay the cerebrospinal fluid (CSF) levels of protein S100B, a biomarker of astrocyte activation in relation to kynurenic acid (KYNA) and nitric oxide (NO) metabolites, nitrate/nitrite (NOx) concentrations in acute relapse multiple sclerosis (MS) patients. Twenty...

  • Nasal nitric oxide in relation to quality-of-life improvements after endoscopic sinus surgery. Fu, Chia-Hsiang; Huang, Chi-Che; Chen, Yi-Wei; Chang, Po-Hung; Lee, Ta-Jen // American Journal of Rhinology & Allergy;Nov/Dec2015, Vol. 29 Issue 6, p187 

    Background: The level of nasal nitric oxide (nNO) in patients with chronic rhinosinusitis (CRS) has been proven to increase after surgical treatment. The relationship between nNO and treatment outcome has not been documented to date. Objective: To evaluate the levels of and changes in nNO after...

  • Evaluation of Tumour Necrosis Factor Alpha, Interleukin-2 Soluble Receptor, Nitric Oxide Metabolites, and Lipids as Inflammatory Markers in Type 2 Diabetes Mellitus. Pereira, Fl�via Ozorio; Frode, T�nia Silvia; Medeiros, Yara Santos // Mediators of Inflammation;2/1/2006, Vol. 2006 Issue 3, p1 

    This study compared the results of tumour necrosis factor alpha (TNF-a), interleukin-2 soluble receptor (sIL-2R), nitric oxide metabolites (NOx), C-reactive protein (CRP), and lipids (total cholesterol, high-density lipoprotein (HDL-cholesterol), low-density lipoprotein (LDL-cholesterol), and...

  • Serum nitric oxide metabolites and high sensitivity C-reactive protein are important biomarkers in non obese, Indian type 2 diabetic males. Sarangi, Rajlaxmi; Padhi, Somanath; Mahapatra, Srikrushna; Bhumika, Nateshan // International Journal of Diabetes in Developing Countries;Sep2012, Vol. 32 Issue 3, p163 

    Inflammation, endothelial dysfunction, and oxidative stress are postulated to be the principal events in the pathogenesis of type 2 diabetes mellitus and its vascular complications. Serum Nitric Oxide metabolites (NO) and high sensitivity C-reactive protein (hs-CRP) were measured in eighty...

  • Association between Human Urotensin II and Essential Hypertension—A 1:1 Matched Case-Control Study. Peng, Hao; Zhang, Mingzhi; Cai, Xiaoqin; Olofindayo, Jennifer; Tan, Anna; Zhang, Yonghong // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Objective: We aimed to evaluate the controversial association between human urotensin II and essential hypertension in untreated hypertensive cases and normotensive controls. Methods: 197 newly diagnosed hypertensive patients and 197 age- and sex-matched normotensive controls were studied....

  • Nitric Oxide-Related Biological Pathways in Patients with Major Depression. Baranyi, Andreas; Amouzadeh-Ghadikolai, Omid; Rothenhäusler, Hans-Bernd; Theokas, Simon; Robier, Christoph; Baranyi, Maria; Koppitz, Michael; Reicht, Gerhard; Hlade, Peter; Meinitzer, Andreas // PLoS ONE;11/18/2015, Vol. 10 Issue 11, p1 

    Background: Major depression is a well-known risk factor for cardiovascular diseases and increased mortality following myocardial infarction. However, biomarkers of depression and increased cardiovascular risk are still missing. The aim of this prospective study was to evaluate, whether...

  • Imbalance Between Nitric Oxide and Dopamine May Underly Aggression in Acute Neurological Patients. Ramírez-Bermudez, J.; Perez-Neri, I.; Montes, S.; Ramirez-Abascal, M.; Nente, F.; Abundes-Corona, A.; Soto-Hernandez, J. L.; Rios, C. // Neurochemical Research;Oct2010, Vol. 35 Issue 10, p1659 

    The neurochemical basis of aggressive behavior in humans is not fully understood. In this study we explored the relationship between aggressiveness (as measured by the Overt Aggression Scale), cognitive performance (as measured by the Mini Mental State Examination), and biochemical markers of...

  • FeNO as biomarker for asthma phenotyping and management. Ricciardolo, F. L. M.; Sorbello, V.; Ciprandi, G. // Allergy & Asthma Proceedings;Jan/Feb2015, Vol. 36 Issue 1, p88 

    The article discusses a research study on nitric oxide (FeNO) as a biomarker for asthma phenotyping and management, published in the 2015 issue of the journal "Allergy Asthma Proceedings."

  • NO in the nose.  // Discover;Jul96, Vol. 17 Issue 7, p32 

    Reports on the discovery by Stockholm, Sweden-based Karolinska Institute researchers that nitric oxide plays an important in the sterile nature of sinuses. Nitric oxide as a vasodilator.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics